Correlation Between Philip Morris and BioNTech

Can any of the company-specific risk be diversified away by investing in both Philip Morris and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Philip Morris and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Philip Morris International and BioNTech SE, you can compare the effects of market volatilities on Philip Morris and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Philip Morris with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Philip Morris and BioNTech.

Diversification Opportunities for Philip Morris and BioNTech

-0.29

Correlation Coefficient

Philip Morris  BioNTech

Very good diversification

The 3 months correlation between Philip and BioNTech is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Philip Morris International and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Philip Morris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Philip Morris International are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Philip Morris i.e., Philip Morris and BioNTech go up and down completely randomly.

Pair Corralation between Philip Morris and BioNTech

Allowing for the 90-day total investment horizon Philip Morris International is expected to generate 0.46 times more return on investment than BioNTech. However, Philip Morris International is 2.19 times less risky than BioNTech. It trades about -0.22 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.12 per unit of risk. If you would invest  13,071  in Philip Morris International on September 24, 2024 and sell it today you would lose (649.00) from holding Philip Morris International or give up 4.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Philip Morris International  vs.  BioNTech SE

Philip Morris Intern

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Philip Morris International are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy primary indicators, Philip Morris is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

BioNTech SE

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Philip Morris and BioNTech

The main advantage of trading using opposite Philip Morris and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Philip Morris position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Philip Morris International and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.